News
Videos
Conferences
Events
Resources
Subscribe

|Videos|April 20, 2017

Oral Targeted Therapies for Ovarian Cancer

Episodes in this series

EP. 1 About Ovarian Cancer

EP. 1 About Ovarian Cancer

EP. 2 Challenges in Ovarian Cancer Detection

EP. 2 Challenges in Ovarian Cancer Detection

EP. 3 Michelle's Ovarian Cancer Story

EP. 3 Michelle's Ovarian Cancer Story

EP. 4 An Ovarian Cancer Diagnosis

EP. 4 An Ovarian Cancer Diagnosis

EP. 5 Caregiver Support and Ovarian Cancer

EP. 5 Caregiver Support and Ovarian Cancer

EP. 6 Genetic Testing for the BRCA Mutation

EP. 6 Genetic Testing for the BRCA Mutation

EP. 7 Deciding Whether to Get Tested for BRCA

EP. 7 Deciding Whether to Get Tested for BRCA

EP. 8 What It Means to Carry a BRCA Mutation

EP. 8 What It Means to Carry a BRCA Mutation

EP. 9 Lowering Your Risk for Ovarian Cancer

EP. 9 Lowering Your Risk for Ovarian Cancer

EP. 10 Who Should Be Tested for the BRCA Mutation?

EP. 10 Who Should Be Tested for the BRCA Mutation?

EP. 11 Diane's Decision to Undergo Surgery to Prevent Cancer

EP. 11 Diane's Decision to Undergo Surgery to Prevent Cancer

EP. 12 Oral Targeted Therapies for Ovarian Cancer

EP. 12 Oral Targeted Therapies for Ovarian Cancer

EP. 13 Deciding Among Therapies for Ovarian Cancer

EP. 13 Deciding Among Therapies for Ovarian Cancer

EP. 14 Finding Support for Ovarian Cancer

EP. 14 Finding Support for Ovarian Cancer

EP. 15 Trustworthy Information on Ovarian Cancer

EP. 15 Trustworthy Information on Ovarian Cancer

Newsletter

Stay up to date on cancer updates, research and education

Related Content

How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments

ByQuincy Attobrah

June 3rd 2026

image of Gilbert.

Lifyorli Extends Survival in Ovarian Cancer Across Taxane Groups

May 29th 2026

Mother's Day

Two Mothers. One Clinical Trial. Two Outcomes.

ByRegina Portnoy

May 9th 2026

Image of Alison

Rezetapopt Shows 44% Response Rate in Ovarian Cancer

ByDr. Alison Schram

April 22nd 2026

Image of Gyn.

FDA Fast Tracks ZW191 for Platinum-Resistant Ovarian Cancer

March 30th 2026

Trending on CURE

Top 5 Takeaways From ASCO 2026 That Patients Should Know

Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status

Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care